Stock Events

Stock Events

Sangui Biotech International 

$0
4
+$0+0% Thursday 00:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
200,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

10NovExpected
Q3 2020
Q4 2020
Q1 2021
Q3 2021
Q4 2021
Q1 2022
Q3 2022
-0
-0
-0
0
Expected EPS
N/A
Actual EPS
0.0001

Financials

-9.02%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
133,000Revenue
-12,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SGBI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap191.53B
Amgen is a biotech firm that develops innovative human therapeutics, competing in similar biotechnological advancements and healthcare solutions as Sangui Biotech International.
Gilead Sciences
GILD
Mkt Cap170.84B
Gilead Sciences is involved in the research and development of biopharmaceuticals, directly competing with Sangui Biotech in the biotech industry, particularly in areas like blood substitutes.
Biogen
BIIB
Mkt Cap26.03B
Biogen focuses on discovering, developing, and delivering worldwide innovative therapies for people living with serious neurological diseases, competing with Sangui Biotech's research and development in healthcare.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.35B
Regeneron Pharmaceuticals is a leading biotechnology company that invents life-transforming medicines for people with serious diseases, competing in the same innovative healthcare solutions market as Sangui Biotech.
Vertex Pharmaceuticals
VRTX
Mkt Cap112.22B
Vertex Pharmaceuticals is known for creating new possibilities in medicine to cure diseases and improve people's lives, competing in the biotech sector alongside Sangui Biotech.
Incyte
INCY
Mkt Cap19.47B
Incyte Corporation specializes in oncology products, competing with Sangui Biotech in the development of treatments for medical conditions.
CRISPR Therapeutics
CRSP
Mkt Cap5.57B
CRISPR Therapeutics is a gene editing company focused on developing gene-based medicines for serious diseases, directly competing with Sangui Biotech's innovative approach to healthcare.

About

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.
Show more...
CEO
Mr. Thomas Striepe
Country
United States
ISIN
US80105B1017

Listings

0 Comments

Share your thoughts

FAQ

What is Sangui Biotech International stock price today?▼
The current price of SGBI is $0 USD — it has increased by +0% in the past 24 hours. Watch Sangui Biotech International stock price performance more closely on the chart.
What is Sangui Biotech International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sangui Biotech International stocks are traded under the ticker SGBI.
What were Sangui Biotech International earnings last quarter?▼
SGBI earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sangui Biotech International revenue for the last year?▼
Sangui Biotech International revenue for the last year amounts to 133,000 USD.
What is Sangui Biotech International net income for the last year?▼
SGBI net income for the last year is -12,000 USD.
In which sector is Sangui Biotech International located?▼
Sangui Biotech International operates in the Health & Wellness sector.
When did Sangui Biotech International complete a stock split?▼
Sangui Biotech International has not had any recent stock splits.
Where is Sangui Biotech International headquartered?▼
Sangui Biotech International is headquartered in Hamburg, United States.